Hana Pharm Co., Ltd (KOSE:A293480) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million pursuant to a trust contract with Mirae Asset Daewoo Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on February 5, 2020. As of August 5, 2019, the company had 342,900 shares in treasury within scope available for dividend and had 0 shares in treasury through other repurchase.